Free Trial
NYSE:QGEN

Qiagen Q2 2025 Earnings Report

Qiagen logo
$49.90 +0.56 (+1.13%)
Closing price 08/1/2025 03:59 PM Eastern
Extended Trading
$49.90 0.00 (0.00%)
As of 08/1/2025 06:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Qiagen EPS Results

Actual EPS
N/A
Consensus EPS
$0.60
Beat/Miss
N/A
One Year Ago EPS
N/A

Qiagen Revenue Results

Actual Revenue
N/A
Expected Revenue
$523.97 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Qiagen Announcement Details

Quarter
Q2 2025
Time
After Market Closes
Conference Call Date
Wednesday, August 6, 2025
Conference Call Time
9:30AM ET

Conference Call Resources

Qiagen Earnings Headlines

Analysts Set QIAGEN N.V. (NYSE:QGEN) Target Price at $49.40
Wall Street Zen Downgrades Qiagen (NYSE:QGEN) to Buy
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.
See More Qiagen Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Qiagen? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Qiagen and other key companies, straight to your email.

About Qiagen

Qiagen (NYSE:QGEN) NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.

View Qiagen Profile

More Earnings Resources from MarketBeat